Phytoestrogenic treatment of vaginal atrophy in postmenopausal wome
Phase 3
Recruiting
- Conditions
- Vaginal Atrophy.Postmenopausal atrophic vaginitis
- Registration Number
- IRCT20171224038036N2
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 76
Inclusion Criteria
Age range from 45 to 65 years
Women with at least one year of menstruation or having a hormonal test with an FSH level higher than 40 international units with a spouse
Having sexual activity
The presence of vaginal atrophy
Exclusion Criteria
Vaginal bleeding with unknown cause
Vaginal infection
Hormone therapy or use of sex hormones 8 weeks before study
Taking isoflavones in the diet
History of suspected breast mass or breast cancer
Hospital admission during research
Unwillingness to continue the study company
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vaginal atrophy. Timepoint: Before intervention, after intervention. Method of measurement: Vaginal smear.
- Secondary Outcome Measures
Name Time Method Dyspareunia. Timepoint: Before the intervention, two weeks after the intervention, four weeks after the intervention, eight weeks after the intervention. Method of measurement: 4 degree self-rating scale.;Sexual performance. Timepoint: Before and after intervention. Method of measurement: Female Sexual Function Index (FSFI).;Sexual satisfaction. Timepoint: Before and after the intervention. Method of measurement: Larsson Sexual Satisfaction Questionnaire.;Severity of menopause symptoms. Timepoint: Before the intervention, two, four, and eight weeks after the intervention. Method of measurement: Menopause Rating Scale Questionnaire.